Latest stories on PHVS
Guggenheim raises Pharvaris stock price target on trial results
Investing.com Analyst Ratings61 · neutralanalyst
Pharvaris price target raised to $44 from $40 at Guggenheim
The Fly61 · neutralanalyst
Pharvaris: 'Strong Buy' Based On Deucrictibant PDUFA And Prophylaxis Trial Win
Seeking Alpha73 · bullishproduct/pr
Pharvaris price target raised to $50 from $42 at Wedbush
The Fly61 · neutralanalyst
Pharvaris price target raised to $65 from $50 at Leerink
The Fly67 · bullishanalyst
Pharvaris price target raised to $62 from $52 at RBC Capital
The Fly65 · bullishanalyst
Pharvaris price target raised to $62 from $46 at Morgan Stanley
The Fly67 · bullishanalyst
Pharvaris price target raised to $65 from $55 at Wells Fargo
The Fly67 · bullishanalyst
Wells Fargo raises Pharvaris stock price target on strong trial data
Investing.com Analyst Ratings63 · neutralanalyst
Pharvaris price target raised to $65 from $52 at Jones
The Fly63 · neutralanalyst
Pharvaris price target raised to $79 from $75 at Citizens
The Fly63 · neutralanalyst
Citizens raises Pharvaris stock price target to $79 on HAE therapy
Investing.com Analyst Ratings61 · neutralanalyst
BCRX Stock Posts Worst Day In Over 6 Months After PHVS Trial Win In Rare Swelling Disease
Stocktwits News28 · bearishproduct/pr
Oppenheimer raises Pharvaris stock price target on trial results
Investing.com Analyst Ratings63 · neutralanalyst
Pharvaris price target raised to $75 from $50 at Oppenheimer
The Fly67 · bullishanalyst
These 2 Biotech Stocks Hit Record Highs Today – What’s Driving The Rallies?
Stocktwits News73 · bullishproduct/pr
Why These Two Hot Biotechs Stocks Just Hit Record Highs
Investors.com78 · bullishearnings
Pharvaris rises 16.7%
The Fly67 · bullishgeneral
Why is Pharvaris stock surging today?
Investing.com Markets50 · neutralgeneral
Pharvaris Unveils CHAPTER-3 Phase 3 Topline Data and HAE Pipeline Milestones
TipRanks65 · bullishproduct/pr
Pharvaris Shares Surge 27% After Deucrictibant Phase 3 Trial Meets Primary Endpoint
InvestorsHub73 · bullishproduct/pr
Pharvaris' genetic disorder drug meets main goal in late-stage trial
Reuters73 · bullishproduct/pr
Pharvaris rises on late-stage trial win for hereditary angioedema drug
Seeking Alpha73 · bullishproduct/pr